Skip to main content
. 2021 Nov 11;375:e066542. doi: 10.1136/bmj-2021-066542

Table 2.

Disability of Arm, Shoulder, Hand (DASH) scores by treatment group

Time point, analysis Usual care) Exercise Between group difference (95% CI)*
No Mean (SD) No Mean (SD) Unadjusted P value Adjusted P value
6 months, ITT 125 20.8 (20.1) 134 18.0 (17.1) 2.76 (−1.79 to 7.31) 0.23 4.60 (0.30 to 8.90) 0.04
12 months, ITT (primary outcome) 138 23.7 (22.9) 132 16.3 (17.6) 7.34 (2.44 to 12.23) <0.01 7.81 (3.17 to 12.44) 0.001
12 months, CACE - - 8.35 (2.85 to 13.84) 0.003 8.74 (3.77 to 13.71) <0.001
Baseline to 6 months 118 −5.3 (19.4) 121 0.7 (17.8) 5.96 (1.23 to 10.70) 0.01 4.60 (0.31. 8.90) 0.04
Baseline to 12 months 130 −5.3 (19.7) 117 2.6 (19.7) 7.98 (3.03 to 12.92) <0.01 7.81 (3.17 to 12.44) 0.001

Scores adjusted for age, baseline DASH, breast surgery, axillary surgery, radiotherapy, and chemotherapy. Mean differences in upper limb function favour exercise intervention.

CACE=complier average causal effect; ITT=intention to treat.

*

Absolute mean difference between treatment groups.